News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immunomedics, Inc. (IMMU) Announces 4 Presentations on Epratuzumab at 2013 American College of Rheumatology Annual Meeting



10/25/2013 9:40:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MORRIS PLAINS, N.J., Oct. 25, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that 4 presentations on studies of epratuzumab in systemic lupus erythematosus (SLE) will be presented at the 2013 Annual Meeting of the American College of Rheumatology (ACR) to be held in San Diego, CA, from October 26 – 30, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES